XR Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

XR Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,872	Closed	-$577K	–	245
2024 Q2	$544K	Buy	5,872 +220	+4%	+$19.7K	0.1%	144
2024 Q1	$536K	Buy	5,652 +372	+7%	+$34.5K	0.02%	196
2023 Q4	$471K	Buy	5,280 +2,382	+82%	+$177K	0.02%	272
2023 Q3	$212K	Buy	+2,898	New	+$231K	0.02%	363
2023 Q2	–	Sell	-5,135	Closed	-$429K	–	476
2023 Q1	$391K	Sell	5,135 -3,777	-42%	-$313K	0.01%	290
2022 Q4	$740K	Sell	8,912 -19,099	-68%	-$1.55M	0.07%	207
2022 Q3	$2.22M	Buy	28,011 +8,550	+44%	+$721K	1.21%	12
2022 Q2	$1.45M	Buy	+19,461	New	+$1.46M	0.48%	34
2022 Q1	–	Sell	-8,647	Closed	-$799K	–	535
2021 Q4	$968K	Buy	8,647 +3,778	+78%	+$456K	0.09%	48
2021 Q3	$612K	Sell	4,869 -5,064	-51%	-$652K	0.28%	74
2021 Q2	$1.34M	Sell	9,933 -5,783	-37%	-$760K	0.59%	30
2021 Q1	$2.13M	Buy	+15,716	New	+$2.35M	0.12%	18
2020 Q2	–	Sell	-3,396	Closed	-$263K	–	323
2020 Q1	$263K	Buy	+3,396	New	+$301K	0.02%	109
2019 Q4	–	Sell	-3,057	Closed	-$264K	–	317
2019 Q3	$233K	Buy	+3,057	New	+$254K	0.03%	113
2019 Q2	–	Sell	-6,074	Closed	-$518K	–	374
2019 Q1	$550K	Sell	6,074 -608	-9%	-$51.7K	0.07%	77
2018 Q4	$479K	Buy	+6,682	New	+$538K	0.21%	62

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

XR Securities's XBI Position: Q3 2024 in Review

XR Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 5,872 shares — an estimated $577K sold.

XR Securities first reported a position in XBI in Q4 2018 and held it in 16 quarters. The position peaked at $2.22M in Q3 2022. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

XR Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
XR Securities sold 5,872 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $577K.
XR Securities first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 16 quarters.
XR Securities's State Street SPDR S&P Biotech ETF position peaked at $2.22M in Q3 2022.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on XR Securities's 13F filing for Q3 2024, filed 25 Oct 2024.